LAFLAMME, Anne Camille,CONNOR, Bronwen Jane,OSULLIVAN, David
申请号：
AU2015203211
公开号：
AU2015203211A1
申请日:
2015.06.05
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
#$%^&*AU2015203211A120150709.pdf#####Abstract The present disclosure is direct to methods and compositions for the treatment of multiple sclerosis using antipsychotic drugs. More specifically, the present disclosure is related to method and compositions for the treatment of multiple sclerosis using atypical antipsychotics such as risperidone, paliperidone or clozapine. Use of a drug with an affinity for both serotonergic 5-HT2 and dopaminergic D2 receptors in the preparation of a medicament for reducing at least one symptom of multiple sclerosis.WO 2012/012147 PCT/US2O1 1/042244 3/20 Fig. 2A 30mq Mv day aft.r hnmun~zaticm: Fig. 2B cli OZ ): iw~ enOIISmVA
